4.8 Editorial Material

Cancer cells stock up in lymph vessels to survive

Journal

NATURE
Volume 585, Issue 7823, Pages 36-37

Publisher

NATURE RESEARCH
DOI: 10.1038/d41586-020-02383-5

Keywords

Cancer; Metabolism; Medical research

Ask authors/readers for more resources

A cellular condition called oxidative stress can kill cancer cells. The finding that skin cancer cells evade such destruction using lipids acquired while passing through lymphatic vessels reveals a mechanism that boosts cancer spread.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis

Monica Vara-Perez, Matteo Rossi, Chris van den Haute, Hannelore Maes, Maria Livia Sassano, Vivek Venkataramani, Bernhard Michalke, Erminia Romano, Kristine Rillaerts, Abhishek D. Garg, Corentin Schepkens, Francesca M. Bosisio, Jasper Wouters, Ana Isabel Oliveira, Peter Vangheluwe, Wim Annaert, Johannes Swinnen, Jean Marie Colet, Joost J. van den Oord, Sarah-Maria Fendt, Massimiliano Mazzone, Patrizia Agostinis

Summary: The study revealed that elevated BNIP3 levels correlated with poorer melanoma patient survival, and depletion of BNIP3 compromised tumor growth. Moreover, BNIP3-deprived melanoma cells displayed increased intracellular iron levels, affecting HIF-1 alpha stabilization.

EMBO JOURNAL (2021)

Editorial Material Cell Biology

Palmitic acid: Enabling the tumor's nerves

H. Furkan Alkan, Patricia Altea-Manzano, Sarah-Maria Fendt

Summary: A recent study published in Nature reveals that dietary palmitic acid can induce an epigenetic memory in cancer cells, leading to enhanced metastasis.

CELL METABOLISM (2022)

Editorial Material Cell Biology

Research is a process

Sarah-Maria Fendt

NATURE CELL BIOLOGY (2022)

Article Multidisciplinary Sciences

Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers

Tom Van Nyen, Melanie Planque, Lilian van Wagensveld, Joao A. G. Duarte, Esther A. Zaal, Ali Talebi, Matteo Rossi, Pierre-Rene Korner, Lara Rizzotto, Stijn Moens, Wout De Wispelaere, Regina E. M. Baiden-Amissah, Gabe S. Sonke, Hugo M. Horlings, Guy Eelen, Emanuele Berardi, Johannes Swinnen, Celia R. Berkers, Peter Carmeliet, Diether Lambrechts, Ben Davidson, Reuven Agami, Sarah-Maria Fendt, Daniela Annibali, Frederic Amant

Summary: Metabolic reprogramming is associated with cancer development and therapy resistance. In this study, the downregulation of serine biosynthesis enzyme PHGDH in a subset of patients is shown to be associated with relapse in platinum-treated ovarian cancers, as well as upregulation of NAD(+) and PARP activity. These findings reveal metabolic vulnerabilities with clinical implications for a subset of platinum-resistant ovarian cancers.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Skeletal progenitors preserve proliferation and self-renewal upon inhibition of mitochondrial respiration by rerouting the TCA cycle

Guillaume Tournaire, Shauni Loopmans, Steve Stegen, Gianmarco Rinaldi, Guy Eelen, Sophie Torrekens, Karen Moermans, Peter Carmeliet, Bart Ghesquiere, Bernard Thienpont, Sarah -Maria Fendt, Nick van Gastel, Geert Carmeliet

Summary: Stem cells bypass mitochondrial oxidative phosphorylation blockade and maintain self-renewal ability by adjusting metabolic pathways.

CELL REPORTS (2022)

Article Oncology

A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma

Sied Kebir, Vivien Ullrich, Pia Berger, Celia Dobersalske, Sarah Langer, Laurel Rauschenbach, Daniel Trageser, Andreas Till, Franziska K. Lorbeer, Anja Wieland, Timo Wilhelm-Buchstab, Ashar Ahmad, Holger Froehlich, Igor Cima, Shruthi Prasad, Johann Matschke, Verena Jendrossek, Marc Remke, Barbara M. Gruener, Alexander Roesch, Jens T. Siveke, Christel Herold-Mende, Tobias Blau, Kathy Keyvani, Frank K. H. van Landeghem, Torsten Pietsch, Jorg Felsberg, Guido Reifenberger, Michael Weller, Ulrich Sure, Oliver Bruestle, Matthias Simon, Martin Glas, Bjoern Scheffler

Summary: This study aimed to identify and target tumor cells that can survive, adapt, and expand under primary therapy in glioblastoma. The researchers found that ALDH1A1+/pAKT+ subclones accumulate and acquire drug resistance in response to temozolomide treatment. They propose a combination therapy of temozolomide and AKT inhibitors as a potential treatment strategy.

CLINICAL CANCER RESEARCH (2023)

Correction Multidisciplinary Sciences

PHGDH heterogeneity potentiates cancer cell dissemination and metastasis (vol 605. pg 747, 2022)

Matteo Rossi, Patricia Altea-Manzano, Margherita Demicco, Ginevra Doglioni, Laura Bornes, Marina Fukano, Anke Vandekeere, Alejandro M. Cuadros, Juan Fernandez-Garcia, Carla Riera-Domingo, Cristina Jauset, Melanie Planque, H. Furkan Alkan, David Nittner, Dongmei Zuo, Lindsay A. Broadfield, Sweta Parik, Antonino Alejandro Pane, Francesca Rizzollo, Gianmarco Rinaldi, Tao Zhang, Shao Thing Teoh, Arin B. Aurora, Panagiotis Karras, Ines Vermeire, Dorien Broekaert, Joke Van Elsen, Maximilian M. L. Knott, Martin F. Orth, Sofie Demeyer, Guy Eelen, Lacey E. Dobrolecki, Ayse Bassez, Thomas Van Brussel, Karl Sotlar, Michael T. Lewis, Harald Bartsch, Manfred Wuhrer, Peter van Veelen, Peter Carmeliet, Jan Cools, Sean J. Morrison, Jean-Christophe Marine, Diether Lambrechts, Massimiliano Mazzone, Gregory J. Hannon, Sophia Y. Lunt, Thomas G. P. Grunewald, Morag Park, Jacco van Rheenen, Sarah-Maria Fendt

NATURE (2022)

Article Oncology

PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma

Emma Phillips, Jorg Balss, Frederic Bethke, Stefan Pusch, Stefan Christen, Thomas Hielscher, Martina Schnoelzer, Michael N. C. Fletcher, Antje Habel, Claudia Tessmer, Lisa-Marie Brenner, Mona Goettmann, David Capper, Christel Herold-Mende, Andreas von Deimling, Sarah-Maria Fendt, Violaine Goidts

Summary: The study reveals the crucial role of PFKFB4 in glioblastoma growth, showing its involvement in regulating the degradation of HIF-1α. Furthermore, the overexpression of PFKFB4 in other cancer entities suggests its potential as a target for cancer therapy.

ONCOGENESIS (2022)

Review Oncology

Metabolite-derived protein modifications modulating oncogenic signaling

Yawen Liu, Anke Vandekeere, Min Xu, Sarah-Maria Fendt, Patricia Altea-Manzano

Summary: Malignant growth is characterized by aberrant cellular features, including metabolic rewiring, inactivation of tumor suppressors and activation of oncogenes which have mutual regulatory relationships. Changes in gene expression/activity impact cellular metabolism and protein modifications, highlighting the importance of understanding the crosstalk between tumor suppressors/oncogenes and metabolism-induced alterations.

FRONTIERS IN ONCOLOGY (2022)

Meeting Abstract Oncology

Targeting SHP2 Reverts Oncogenic Mediated Resistance to KRAS-G12C Inhibition

A. I. Tuens, C. S. L. Ho, H. -U. Schildhaus, M. Wiesweg, B. M. Gruener, B. Hegedues, M. Schuler, A. Schramm, S. Oeck

JOURNAL OF THORACIC ONCOLOGY (2022)

Meeting Abstract Endocrinology & Metabolism

Skeletal progenitors preserve self-renewal in absence of mitochondrial respiration by metabolically repressed DNA demethylase activity

Guillaume Tournaire, Shauni Loopmans, Steve Stegen, Guy Eelen, Sophie Torrekens, Karen Moermans, Peter Carmeliet, Bart Ghesquiere, Bernard Thienpont, Sarah-Maria Fendt, Nick van Gastel, Geert Carmeliet

JOURNAL OF BONE AND MINERAL RESEARCH (2022)

Article Endocrinology & Metabolism

Altered propionate metabolism contributes to tumour progression and aggressiveness

Ana P. Gomes, Didem Ilter, Vivien Low, Stanislav Drapela, Tanya Schild, Edouard Mullarky, Julie Han, Ilaria Elia, Dorien Broekaert, Adam Rosenzweig, Michal Nagiec, Joana B. Nunes, Bethany E. Schaffer, Anders P. Mutvei, John M. Asara, Lewis C. Cantley, Sarah-Maria Fendt, John Blenis

Summary: The study reveals that alterations in propionate metabolism contribute to cancer aggressiveness by causing the accumulation of methylmalonic acid, a by-product of propionate metabolism. Dysregulation of propionate metabolism leads to a pro-aggressive signature in breast and lung cancer cells, increasing their metastatic potential. The downregulation of methylmalonyl coenzyme A epimerase (MCEE) is mediated by an extracellular signal-regulated kinase 2-driven transcription factor Sp1/early growth response protein 1 transcriptional switch driven by metastatic signaling at its promoter level.

NATURE METABOLISM (2022)

Article Endocrinology & Metabolism

Nuclear PHGDH protects cancer cells from nutrient stress

Daniela Annibali, Sarah-Maria Fendt

Summary: The study demonstrates the transition of PHGDH to the nucleus following nutrient stress, impacting the activity of c-Jun and contributing to sustained cancer cell proliferation.

NATURE METABOLISM (2021)

Review Oncology

Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids

Erica Pranzini, Elisa Pardella, Paolo Paoli, Sarah-Maria Fendt, Maria Letizia Taddei

Summary: This study emphasizes the important role of amino acid metabolic reprogramming in cancer therapy, with amino acids playing a crucial role in acquiring resistance to anticancer drugs, especially in terms of the resistance of cancer stem cells.

TRENDS IN CANCER (2021)

Article Cell & Tissue Engineering

SOX9-induced Generation of Functional Astrocytes Supporting Neuronal Maturation in an All-human System

Katrien Neyrinck, Johanna Van den Daele, Tim Vervliet, Jonathan De Smedt, Keimpe Wierda, Melissa Nijs, Tom Vanbokhoven, Astrid D'hondt, Melanie Planque, Sarah-Maria Fendt, Pei-Yu Shih, Frederik Seibt, Juan Pita Almenar, Mohamed Kreir, Devesh Kumar, Vania Broccoli, Geert Bultynck, Andreas Ebneth, Alfredo Cabrera-Socorro, Catherine Verfaillie

Summary: By overexpressing SOX9 in pluripotent stem cells, functionally mature human astrocytes can be generated, displaying comparable functional properties to primary human astrocytes. The electrophysiological properties of neurons co-cultured with these astrocytes are similar to murine primary cultures. This method allows for scaled-up production for high-throughput analysis, aiding in drug development and reducing animal use in biomedical research.

STEM CELL REVIEWS AND REPORTS (2021)

No Data Available